- Home
- Articles
- latamerica
- validated antibody
Validated Antibody Articles & Analysis
8 articles found
Recombinant extracellular domains of CCR1 are used to: l Map ligand-binding interactions with chemokines and antibodies l Screen for small-molecule or peptide inhibitors l Generate high-affinity monoclonal antibodies for therapeutic exploration In contrast, full-length CCR1 expressed in mammalian or insect cells enables GPCR signaling assays, including ...
Single-domain antibodies, also known as nanobodies or VHH antibodies, are a unique class of antibody fragments derived from the immune systems of camelids, such as llamas and alpacas. ...
These cells are the sources of antibody generation, and their internal DNA contains antibody sequence information.Extract RNAThe RNA in immune cells is the carrier of antibody sequence information, and the sample needs to be extracted for RNA.Transcribe to cDNAIt needs to be transcribed into cDNA by reverse transcriptase.Amplify ...
It can be applied to signal pathway research, tumor biomarker research, post-translational modification analysis, and serve as an alternative to antibody-based protein quantification methods for targeted protein quantification.What are the Targeted Protein Quantification ...
BetaLifeScience provides high-quality MMP-3 antigens and antibodies that have been validated on LF (Lateral Flow) and CLIA (Chemiluminescent Immunoassay) platforms, contributing to the development of in vitro diagnostic test kits. High affinity reaching pM level Strong stability, validated through freeze-thaw and accelerated stability testing ...
Featured Product 1: Recombinant Human IL-2 Product Features: Designed for cellular therapy applications Expressed in E. coli, tag-free Produced using non-animal source materials and pharmaceutical excipients Sterile, free of aminobenzyl penicillin, no HBV, HCV, HIV and other pathogens, mycoplasma-free Endotoxins less than 10EU/mg, host protein residues less than 0.005%, exogenous DNA residues ...
It is well-known for its role in promoting type 2 immune responses, such as allergic diseases. In 2021, a monoclonal antibody targeting TSLP was approved for the treatment of severe asthma. ...
Antibody-drug conjugates (ADCs) usually consist of monoclonal antibodies (mAbs) covalently linked to cytotoxic drugs via chemical linkers. ...
